Targeting GPVI as a novel antithrombotic strategy
Robert K Andrews, Jane F Arthur, Elizabeth E Gardiner Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia Abstract: While platelet activation is essential to maintain blood vessel patency and minimize loss of blood upon injury, untimely or excessive activity can lead...
Main Authors: | Andrews RK, Arthur JF, Gardiner EE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-05-01
|
Series: | Journal of Blood Medicine |
Online Access: | http://www.dovepress.com/targeting-gpvi-as-a-novel-antithrombotic-strategy-a16928 |
Similar Items
-
Gene targeting implicates Cdc42 GTPase in GPVI and non-GPVI mediated platelet filopodia formation, secretion and aggregation.
by: Huzoor Akbar, et al.
Published: (2011-01-01) -
Discovery of novel GPVI receptor antagonists by structure-based repurposing.
by: Lewis Taylor, et al.
Published: (2014-01-01) -
Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity
by: María N. Barrachina, et al.
Published: (2019-04-01) -
Studies on regulation and signaling of the platelet glycoproteins GPV and GPVI
by: Strehl, Amrei
Published: (2006) -
mTOR regulates GPVI-mediated platelet activation
by: Longsheng Wang, et al.
Published: (2021-05-01)